Study VanDeVijver-ER-neg
Study informations
122 subnetworks in total page | file
1481 genes associated page | file
Enriched GO terms page
General informations
General Index page
Study Index page
Subnetwork 1219
score
Dataset | Score | P-val 1 | P-val 2 | P-val 3 | Fisher Score |
Desmedt | 0.3327 | 1.554e-03 | 2.800e-05 | 1.645e-01 | 7.156e-09 |
IPC | 0.3389 | 3.520e-01 | 1.812e-01 | 9.363e-01 | 5.974e-02 |
Loi | 0.4839 | 3.900e-05 | 0.000e+00 | 4.973e-02 | 0.000e+00 |
Schmidt | 0.6014 | 1.000e-06 | 0.000e+00 | 1.100e-01 | 0.000e+00 |
Wang | 0.2569 | 7.774e-03 | 6.702e-02 | 2.317e-01 | 1.207e-04 |
Expression data for subnetwork 1219 in each dataset
Desmedt |
IPC |
Loi |
Schmidt |
Wang |
Subnetwork structure for each dataset
- Desmedt

Score for each gene in subnetwork 1219 in each dataset
Gene Symbol | Links | Frequency | Frequency Rank | Subnetwork score rank | Global rank |
Desmedt | IPC | Loi | Schmidt | Wang |
CELF2 |  | 3 | 265 | 634 | 620 | 0.083 | -0.124 | -0.086 | -0.056 | 0.002 |
SFRS17A |  | 2 | 391 | 634 | 628 | -0.022 | -0.036 | 0.169 | -0.225 | -0.078 |
CDKN1A |  | 56 | 4 | 1 | 3 | 0.075 | 0.064 | 0.254 | 0.030 | 0.082 |
EBI3 |  | 1 | 652 | 634 | 653 | 0.261 | -0.033 | -0.324 | -0.212 | -0.091 |
ELAVL2 |  | 4 | 198 | 419 | 417 | 0.096 | 0.085 | 0.115 | 0.158 | -0.076 |
CTNNB1 |  | 33 | 14 | 33 | 29 | 0.202 | -0.113 | 0.187 | 0.159 | 0.239 |
CDC42 |  | 44 | 9 | 1 | 6 | 0.036 | 0.047 | 0.242 | -0.027 | -0.042 |
PAK2 |  | 20 | 24 | 1 | 11 | -0.019 | 0.014 | 0.161 | 0.081 | 0.062 |
UBE2U |  | 1 | 652 | 634 | 653 | undef | -0.113 | 0.255 | undef | undef |
TAX1BP3 |  | 5 | 148 | 552 | 541 | 0.292 | 0.150 | 0.219 | 0.070 | 0.206 |
PPP2R2B |  | 35 | 13 | 1 | 8 | -0.200 | 0.124 | -0.019 | 0.029 | -0.073 |
RBPMS |  | 7 | 100 | 419 | 407 | 0.246 | 0.043 | 0.108 | 0.066 | -0.077 |
S100A9 |  | 18 | 26 | 398 | 382 | 0.154 | 0.117 | 0.043 | -0.110 | -0.045 |
CAV2 |  | 52 | 6 | 117 | 118 | 0.380 | -0.013 | 0.165 | 0.065 | 0.101 |
MDFI |  | 2 | 391 | 634 | 628 | -0.118 | -0.075 | -0.001 | 0.177 | -0.112 |
PGLS |  | 1 | 652 | 634 | 653 | 0.209 | -0.089 | 0.039 | -0.156 | -0.076 |
PLSCR1 |  | 7 | 100 | 634 | 614 | 0.058 | 0.202 | -0.159 | 0.091 | -0.105 |
SERTAD4 |  | 7 | 100 | 1 | 20 | undef | 0.173 | 0.169 | undef | undef |
RNF11 |  | 1 | 652 | 634 | 653 | 0.149 | -0.082 | 0.152 | 0.045 | 0.154 |
C12orf12 |  | 3 | 265 | 419 | 419 | undef | 0.135 | 0.002 | undef | undef |
OGDH |  | 1 | 652 | 634 | 653 | 0.182 | -0.229 | 0.138 | -0.289 | -0.151 |
NPDC1 |  | 3 | 265 | 339 | 348 | 0.190 | -0.019 | 0.221 | 0.044 | -0.146 |
EGFR |  | 72 | 2 | 117 | 117 | 0.064 | -0.195 | 0.240 | -0.205 | 0.065 |
RERE |  | 4 | 198 | 634 | 615 | 0.077 | -0.284 | 0.209 | -0.027 | 0.074 |
TRIM47 |  | 1 | 652 | 634 | 653 | undef | 0.083 | 0.109 | undef | undef |
CRK |  | 27 | 17 | 206 | 193 | 0.232 | -0.116 | 0.106 | 0.090 | 0.017 |
HOXA9 |  | 2 | 391 | 634 | 628 | -0.055 | 0.057 | 0.136 | 0.040 | 0.018 |
MLL4 |  | 4 | 198 | 412 | 409 | -0.032 | -0.093 | 0.052 | -0.101 | -0.153 |
GRIN2D |  | 18 | 26 | 33 | 32 | undef | 0.058 | 0.155 | 0.000 | undef |
EYA2 |  | 5 | 148 | 419 | 415 | 0.028 | -0.034 | 0.113 | -0.142 | -0.019 |
DHRS7B |  | 4 | 198 | 419 | 417 | 0.261 | 0.031 | -0.058 | -0.114 | 0.009 |
MYST3 |  | 1 | 652 | 634 | 653 | 0.202 | -0.075 | 0.035 | 0.012 | -0.010 |
GO Enrichment output for subnetwork 1219 in each dataset
Name | Accession Number | Link | P-val | Corrected P-val |
nuclear migration | GO:0007097 |  | 3.825E-07 | 8.797E-04 |
positive regulation of pseudopodium assembly | GO:0031274 |  | 3.825E-07 | 4.398E-04 |
macrophage differentiation | GO:0030225 |  | 7.631E-07 | 5.85E-04 |
regulation of lipid kinase activity | GO:0043550 |  | 1.332E-06 | 7.66E-04 |
establishment of nucleus localization | GO:0040023 |  | 1.332E-06 | 6.128E-04 |
indolalkylamine metabolic process | GO:0006586 |  | 3.182E-06 | 1.22E-03 |
nucleus localization | GO:0051647 |  | 3.182E-06 | 1.045E-03 |
regulation of cell projection assembly | GO:0060491 |  | 4.534E-06 | 1.303E-03 |
filopodium assembly | GO:0046847 |  | 6.219E-06 | 1.589E-03 |
microspike assembly | GO:0030035 |  | 8.272E-06 | 1.902E-03 |
regulation of protein complex assembly | GO:0043254 |  | 3.487E-05 | 7.291E-03 |
Name | Accession Number | Link | P-val | Corrected P-val |
melatonin biosynthetic process | GO:0030187 |  | 2.825E-10 | 6.9E-07 |
indolalkylamine biosynthetic process | GO:0046219 |  | 8.456E-10 | 1.033E-06 |
indolalkylamine metabolic process | GO:0006586 |  | 3.971E-08 | 3.233E-05 |
nuclear migration | GO:0007097 |  | 4.166E-07 | 2.545E-04 |
positive regulation of pseudopodium assembly | GO:0031274 |  | 4.166E-07 | 2.036E-04 |
regulation of lipid kinase activity | GO:0043550 |  | 1.162E-06 | 4.731E-04 |
establishment of nucleus localization | GO:0040023 |  | 1.162E-06 | 4.055E-04 |
macrophage differentiation | GO:0030225 |  | 1.739E-06 | 5.311E-04 |
biogenic amine biosynthetic process | GO:0042401 |  | 2.774E-06 | 7.53E-04 |
Wnt receptor signaling pathway through beta-catenin | GO:0060070 |  | 3.403E-06 | 8.313E-04 |
nucleus localization | GO:0051647 |  | 3.403E-06 | 7.557E-04 |
Name | Accession Number | Link | P-val | Corrected P-val |
indolalkylamine biosynthetic process | GO:0046219 |  | 2.948E-10 | 7.092E-07 |
indolalkylamine metabolic process | GO:0006586 |  | 1.92E-08 | 2.31E-05 |
nuclear migration | GO:0007097 |  | 4.313E-07 | 3.459E-04 |
positive regulation of pseudopodium assembly | GO:0031274 |  | 4.313E-07 | 2.594E-04 |
regulation of lipid kinase activity | GO:0043550 |  | 7.532E-07 | 3.624E-04 |
macrophage differentiation | GO:0030225 |  | 7.532E-07 | 3.02E-04 |
establishment of nucleus localization | GO:0040023 |  | 1.203E-06 | 4.134E-04 |
Wnt receptor signaling pathway through beta-catenin | GO:0060070 |  | 2.567E-06 | 7.719E-04 |
biogenic amine biosynthetic process | GO:0042401 |  | 2.569E-06 | 6.866E-04 |
hormone biosynthetic process | GO:0042446 |  | 3.248E-06 | 7.816E-04 |
nucleus localization | GO:0051647 |  | 3.522E-06 | 7.703E-04 |
Name | Accession Number | Link | P-val | Corrected P-val |
nuclear migration | GO:0007097 |  | 3.825E-07 | 8.797E-04 |
positive regulation of pseudopodium assembly | GO:0031274 |  | 3.825E-07 | 4.398E-04 |
macrophage differentiation | GO:0030225 |  | 7.631E-07 | 5.85E-04 |
regulation of lipid kinase activity | GO:0043550 |  | 1.332E-06 | 7.66E-04 |
establishment of nucleus localization | GO:0040023 |  | 1.332E-06 | 6.128E-04 |
indolalkylamine metabolic process | GO:0006586 |  | 3.182E-06 | 1.22E-03 |
nucleus localization | GO:0051647 |  | 3.182E-06 | 1.045E-03 |
regulation of cell projection assembly | GO:0060491 |  | 4.534E-06 | 1.303E-03 |
filopodium assembly | GO:0046847 |  | 6.219E-06 | 1.589E-03 |
microspike assembly | GO:0030035 |  | 8.272E-06 | 1.902E-03 |
regulation of protein complex assembly | GO:0043254 |  | 3.487E-05 | 7.291E-03 |
Name | Accession Number | Link | P-val | Corrected P-val |
nuclear migration | GO:0007097 |  | 3.825E-07 | 8.797E-04 |
positive regulation of pseudopodium assembly | GO:0031274 |  | 3.825E-07 | 4.398E-04 |
macrophage differentiation | GO:0030225 |  | 7.631E-07 | 5.85E-04 |
regulation of lipid kinase activity | GO:0043550 |  | 1.332E-06 | 7.66E-04 |
establishment of nucleus localization | GO:0040023 |  | 1.332E-06 | 6.128E-04 |
indolalkylamine metabolic process | GO:0006586 |  | 3.182E-06 | 1.22E-03 |
nucleus localization | GO:0051647 |  | 3.182E-06 | 1.045E-03 |
regulation of cell projection assembly | GO:0060491 |  | 4.534E-06 | 1.303E-03 |
filopodium assembly | GO:0046847 |  | 6.219E-06 | 1.589E-03 |
microspike assembly | GO:0030035 |  | 8.272E-06 | 1.902E-03 |
regulation of protein complex assembly | GO:0043254 |  | 3.487E-05 | 7.291E-03 |